Loading…
Reported covered position: CHIEF OF STAFF, US SENATE
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2012 · first_quarter · Q1
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research. Issues related to agriculture research; issues related to veterinary medicine.
Issues related to federal stormwater policy and issues related to biomass and forestry.
Source: Senate LDA
| PYNG MEDICAL USA |
| 10 |
| 2010–2011 |
| SEGALE PROPERTIES | 10 | 2009–2010 |
| PORT OF SEATTLE | 9 | 2007–2010 |
| SIXKILLER CONSULTING, LLC | 8 | 2010–2012 |
| COMMUNITY MEDICAL CENTER | 7 | 2007–2010 |
| NISQUALLY INDIAN TRIBE | 7 | 2007–2009 |
| DELTA AIR LINES INC AND ITS SUBSIDIARY NORTHWEST AIRLINES INC (FKA DELTA AI | 5 | 2007–2008 |
| B E MEYERS AND COMPANY INC | 4 | 2007–2008 |
| BOEING COMPANY | 4 | 2007–2009 |
| CHALDEAN ASSYRIAN SYRIAC COUNSEL OF AMERICA | 4 | 2007–2008 |
| DOWNLOAD FAIRNESS COALITION | 4 | 2011 |
| PARTNERSHIP FOR A DRUG FREE AMERICA | 4 | 2007–2008 |
| SNOHOMISH COUNTY PUD | 4 | 2007 |
| STARK & ROTH INC | 4 | 2007–2008 |
| ALEUTIAN SPRAY FISHERIES INC | 3 | 2007 |
| ALLIANCE OF AUTOMOBILE MANUFACTURERS | 3 | 2007 |
| ALLIANT TECHSYSTEMS INC | 3 | 2007 |
| AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) | 3 | 2010 |
| AMERICAN TRUCKING ASSOCIATION | 3 | 2007 |
| AMI JET CHARTER INC | 3 | 2007 |
| CITY OF PHOENIX | 3 | 2006–2007 |
| CORRECTIONS CORPORATION OF AMERICA | 3 | 2007–2008 |
| DAVIS WRIGHT TREMAINE LLP (ON BEHALF OF SWEDISH MEDICAL CTR & PROVIDENCE HEALTH) | 3 | 2011 |
| FEDEX | 3 | 2007 |
| GIGOPTIX INC | 3 | 2007–2010 |
| GUARDIAN TECHNOLOGIES INTERNATIONAL | 3 | 2007 |
| J3 LLC | 3 | 2007 |
| JPMORGAN CHASE & CO | 3 | 2009–2011 |
| MENTOR NETWORK | 3 | 2007–2008 |
| NAVERUS INC | 3 | 2007 |
| S&B PUBLIC SOLUTIONS LLC DBA HILLTOP PUBLIC SOLUTIONS ON BEHALF OF GENENTECH | 3 | 2007 |
| SONY ELECTRONICS INC. | 3 | 2007 |
| THE CHILDREN'S INVESTMENT FUND VIA SCHULTE ROTH & ZABEL LLP | 3 | 2007 |
| UNITED TECHNOLOGIES CORP | 3 | 2007 |
| AECOM (FKA URS CORPORATION) | 2 | 2007 |
| AKERMIN INC | 2 | 2007 |
| AMERICAN AIRLINES INC. | 2 | 2007 |
| ASPEN AEROGELS INC | 2 | 2007 |
| BATTELLE MEMORIAL INSTITUTE | 2 | 2007 |
| CALYPSO MEDICAL TECHNOLOGIES, INC. | 2 | 2007 |
| CHEROKEE NATION VIA ORRICK HERRINGTON & SUTCLIFFE LLP | 2 | 2007 |
| CITY OF AUBURN | 2 | 2007 |
| CITY OF EVERETT | 2 | 2007 |
| COPART INC | 2 | 2007 |
| DEWEY SQUARE GROUP ON BEHALF OF THE MENTOR NETWORK | 2 | 2007 |
| DIMENSION 4 | 2 | 2007 |
| EASTMAN CHEMICAL COMPANY | 2 | 2007 |
| EVERGREEN INTERNATIONAL AVIATION, INC. | 2 | 2007 |
| EXPEDIA | 2 | 2007 |
| GHFB, LLP (FORMERLY KNOWN AS POWER RESOURCE MANAGERS) | 2 | 2007 |
| GOOGLE, INC. | 2 | 2009 |
| GROUNDFISH FORUM | 2 | 2007 |
| HONEYWELL INTERNATIONAL | 2 | 2007 |
| IMPERIUM RENEWABLES (FORMERLY KNOWN AS SEATTLE BIODIESEL) | 2 | 2007 |
| INTELLECTUAL PROPERTY OWNERS ASSN | 2 | 2007 |
| INTL RAM ASSOC | 2 | 2007 |
| LEIDOS, INC. (FKA SCIENCE APPLICATIONS INTERNATIONAL CORPORATION OR SAIC) | 2 | 2007 |
| MICROVISION | 2 | 2007 |
| MILCOM VENTURE PARTNERS | 2 | 2007 |
| MITSUBISHI GAS CHEMICAL AMERICA, INC. | 2 | 2008 |
| NEAH POWER SYSTEMS | 2 | 2007 |
| NORTHROP GRUMMAN CORP | 2 | 2007 |
| PERSONAL WATERCRAFT INDUSTRY ASSOCIATION | 2 | 2008 |
| REACH OUT & READ NATL CENTER | 2 | 2007 |
| RENAISSANCERE HOLDINGS LTD. | 2 | 2009 |
| RETICA SYSTEMS INC | 2 | 2007 |
| SAN DIEGO COUNTY REGIONAL AIRPORT AUTHORITY | 2 | 2007 |
| SAVI NETWORKS | 2 | 2007 |
| SAVI TECHNOLOGY | 2 | 2007 |
| SNOHOMISH COUNTY | 2 | 2007 |
| SURESCAN CORP | 2 | 2007 |
| TESLA MOTORS, INC. | 2 | 2008 |
| THE BABCOCK & WILCOX COMPANY (FKA BWX TECHNOLOGIES, INC.) | 2 | 2007 |
| TULALIP & JOINT BOARD FOR MANAGING THE CONSTRUCTION OF THE EVERETT TO TULALIP WA | 2 | 2007 |
| Time Warner Inc. | 2 | 2009 |
| WASHINGTON CLOSURE HANFORD LLC | 2 | 2007 |
| XM SATELITE RADIO | 2 | 2007 |
| ABACUS TECHNOLOGY CORPORATION | 1 | 2007 |
| ARENA INDUSTRIES LLC | 1 | 2007 |
| BATTELLE MEMORIAL INSTITUTE, PACIFIC NORTHWEST DIVISION | 1 | 2009 |
| BETTER PLACE, INC. | 1 | 2009 |
| CHOOSE RESPONSIBILITY, INC. | 1 | 2009 |
| CITY OF SEATTLE | 1 | 2009 |
| CITY OF TACOMA | 1 | 2009 |
| CURTISS-WRIGHT CORPORATION | 1 | 2008 |
| ENTERPRISE COMMUNITY PARTNERS, INC. | 1 | 2009 |
| GENERAL DYNAMICS CORPORATION | 1 | 2007 |
| GREATPOINT ENERGY | 1 | 2010 |
| ON TIME SYSTEMS | 1 | 2007 |
| SCIENCE CENTER | 1 | 2007 |
| SUQUAMISH TRIBE | 1 | 2008 |
| TIME WARNER CABLE INC | 1 | 2009 |
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
To amend the Act of August 9, 1955, to modify a provision relating to leases involving certain Indian tribes.
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Legislation to modify leasing provisions for lands held by certain Indian Tribes (H.R.4401, S.2906). Prevent all Cigarette Trafficking Act (PL 111-117).
A bill to amend the Act of August 9, 1955, to modify a provision relating to leases involving certain Indian tribes.
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Legislation to modify leasing provisions for lands held by certain Indian Tribes (H.R.4401, S.2906). Prevent all Cigarette Trafficking Act (PL 111-117).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: COMMUNITY MEDICAL CENTER · Firm: SIGNAL GROUP CONSULTING, LLC
FY2011 House and Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills (S.3686)- advocated for funding related to Community Medical Center projects and programs.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Fair Prescription Drug Competition Act
Client: AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to Fraternal's 501(c)(8) tax exempt status.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Early Treatment for HIV Act of 2007
Client: GIGOPTIX INC · Firm: SIGNAL GROUP CONSULTING, LLC
H.R.3326, FY2010 DOD Appropriations bill (PL 111-118)- funding for polymer-based optical communications technology. Issues related to congressional consideration of President's defense budget. The FY2011 House and Senate DOD Appropriations bills.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy of Washington State. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy of Washington State. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Pathway for Biosimilars Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
National Freight Mobility Infrastructure Act
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
H.R. 2707, National Freight Mobility Infrastructure Act. Freight Mobility Issues; FAA Reauthorization. Identified funding opportunities from H.R. 1, the American Recovery and Reinvestment Act. Monitored the Surface Transportation Authorization Act of 2009, including high priority project requests. FY2010 transportation appropriations legislation- funding for local governments.
Close the SILO/LILO Loophole Act of 2009
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
Monitored legislative activity related to the Surface Transportation Authorization Act of 2009, including high priority projects. Monitored legislative activity around the SILO/LILO Loophole Act (H.R. 3439/S. 1341, Close the SILO/LILO Loophole Act of 2009). Issues related to local project planning and finance.
To amend the Act of August 9, 1955, to modify a provision relating to leases involving certain Indian tribes.
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Legislation to modify leasing provisions for lands held by certain Indian Tribes (H.R.4401, S.2906).
Federal Surface Transportation Policy and Planning Act of 2009
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Monitored issues related to port infrastructure and competitiveness. S.1036 Federal Surface Transportation Policy & Planning Act.
Close the SILO/LILO Loophole Act of 2009
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
Monitored legislative activity related to the Surface Transportation Authorization Act of 2009, including high priority projects. Monitored legislative activity around the SILO/LILO Loophole Act (H.R. 3439/S. 1341, Close the SILO/LILO Loophole Act of 2009). Issues related to local project planning and finance.
American Clean Energy Leadership Act of 2009
Client: ENTERPRISE COMMUNITY PARTNERS, INC. · Firm: SIGNAL GROUP CONSULTING, LLC
Monitored and advocated on energy efficiency including Green Act and H.R.2454, the American Clean Energy and Security Act and Senate energy bill, S.1462, the American Clean Energy Leadership Act of 2009. Analyzed opportunities in Department of Energy programs, including weatherization. Advocated for energy efficiency multifamily housing funding. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
American Clean Energy Leadership Act of 2009
Client: ENTERPRISE COMMUNITY PARTNERS, INC. · Firm: SIGNAL GROUP CONSULTING, LLC
Provided support and advocated on energy related issues, including energy efficiency and housing. Monitored and advocated on energy efficiency including Green Act and H.R.2454, the American Clean Energy and Security Act and Senate energy bill, S.1462, the American Clean Energy Leadership Act of 2009. Analyzed opportunities in Department of Energy programs, including weatherization. Advocated for energy efficiency multifamily housing funding. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
American Clean Energy Leadership Act of 2009
Client: ENTERPRISE COMMUNITY PARTNERS, INC. · Firm: SIGNAL GROUP CONSULTING, LLC
Provided support on energy efficient housing opportunities in H.R.1, the American Recovery and Reinvestment Act of 2009 (PL 111-5). Monitored and advocated for energy efficient housing provisions in American Clean Energy and Security Act and Senate energy bill, S.1462, the American Clean Energy Leadership Act of 2009. Monitored housing proposals, including Choice Neighborhoods and public housing proposals. Monitored legislative and regulatory action on energy efficient housing. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
A bill to amend the Act of August 9, 1955, to modify a provision relating to leases involving certain Indian tribes.
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Legislation to modify leasing provisions for lands held by certain Indian Tribes (H.R.4401, S.2906).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHRMA (ON BEHALF OF WE WORK FOR HEALTH) · Firm: SIGNAL GROUP CONSULTING, LLC
Issues related to the impact of the bio-pharmaceutical industry on the economy of Washington State. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Physician Pathology Services Continuity Act of 2007
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
HR 1105- Omnibus Appropriations Act- full funding grant and funding for transit programs. HR 1 - American Recovery and Reinvestment Act 2009- transit funding. FY2010 Budget blueprint and appropriations process for funding to support local initiatives.
Physician Pathology Services Continuity Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Freight Mobility Issues; FAA Reauthorization, House (HR 2881) and Senate Federal Aviation Administration Extension Act of 2007 - All provisions. H.R. 1105 FY09 Omnibus- frieght mobility funding. Identify funding opportunities from H.R. 1, the American Recovery and Reinvestment Act.
Physician Pathology Services Continuity Act of 2007
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
HR 1105- Omnibus Appropriations Act- for funding for local transit, commuter rail, and intercity passenger rail programs. HR 1 - American Recovery and Reinvestment Act 2009- transit funding. Reauthorization of surface transportation Legislation.
Physician Pathology Services Continuity Act of 2007
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
HR 1105- Omnibus Appropriations Act 2009, Transportation / HUD Appropriations Bills for funding for Indian programs and services. HR 1- American Recovery and Reinvestment Act, for funding for Indian programs and local projects. FY10 budget blueprint and opportunities for funding to support local initiatives.
Physician Pathology Services Continuity Act of 2007
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
HR 1105- Omnibus Appropriations Act 2009, funding for the Upper Columbia United Tribes and related habitat protection and restoration activities.
To include B20 biodiesel blends as an alternative fuel for corporate average fuel economy purposes.
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Monitored climate change legislation- H.R. 2454 American Clean Energy and Security Act. Identified funding opportunities from H.R. 1, the American Recovery and Reinvestment Act.
A bill to suspend temporarily the duty on porcelain lamp-holder housings containing sockets.
Client: CITY OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S. 3261) Transportation Housing & Urban Development and related agencies Appropriations Act, 2009. HR1- The American Recovery & Reinvestment Act. Public Law 109-59-Safe Accountable Flexible Efficient Transportation Equity Act- A Legacy for Users (SAFETEA-LU)
A bill to suspend temporarily the duty on porcelain lamp-holder housings containing sockets.
Client: CITY OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S. 3261) Transportation Housing & Urban Development and related agencies Appropriations Act, 2009. HR1- The American Recovery & Reinvestment Act. Public Law 109-59-Safe Accountable Flexible Efficient Transportation Equity Act- A Legacy for Users (SAFETEA-LU)
Revising the congressional budget for the United States Government for fiscal year 2008, establishing the congressional budget for the United States Government for fiscal year 2009, and setting forth appropriate budgetary levels for fiscal years 2010 through 2013.
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
Full Funding Grant Agreement; funding for transit programs; FY 09 Transportation Appropriations Bills-funding related to transit, H Con Res 312 House Budget Resolution; S Con Res 70 Senate Budget Resolution;
Indian Health Care Improvement Act Amendments of 2007
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Monitor legislation affecting Federally recognized Indian Tribes, including reauthorization of Indian Health Care Improvement Act (S 1200 & HR 1328) and legislation related to natural resource management
Indian Health Care Improvement Act Amendments of 2007
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Monitor legislation affecting Federally recognized Indian Tribes, including reauthorization of Indian Health Care Improvement Act (S 1200 & HR 1328) and legislation related to natural resource management
Indian Health Care Improvement Act Amendments of 2007
Client: KALISPEL TRIBE OF INDIANS · Firm: SIGNAL GROUP CONSULTING, LLC
Monitor legislation affecting Federally recognized Indian Tribes, including reauthorization of Indian Health Care Improvement Act (S 1200 & HR 1328) and legislation related to natural resource management
Federal Aviation Administration Extension Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Freight Mobility Issues; FAA Reauthorization, HR 3540 Aviation Trust Fund Reauthorization - All provisions
Federal Aviation Administration Extension Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Freight Mobility Issues; FAA Reauthorization, HR 3540 Aviation Trust Fund Reauthorization - All provisions
Federal Aviation Administration Extension Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
House (HR 3540/ PL 110-337) and Senate Federal Aviation Administration Act 2007. Aviation Security, monitored legislation for impact to airport. All FAA Reauthorization Extensions.
Federal Aviation Administration Extension Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Freight Mobility Issues; FAA Reauthorization, House (HR 3540) and Senate Federal Aviation Administration Extension Act of 2007 - All provisions
Federal Aviation Administration Extension Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
HR 3540 Aviation Trust Fund Reauthorization - all provisions. Aviation Security - monitored legislation for impact to airport.
Homeowners Property Tax Relief Act of 2007
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Airport Security Issues, Passenger screening. Passenger Vessel Safety Act of 1993 modifications. House (HR 3953) and Senate Aviation Security and Antiterrorism Act of 1996.
Defenders of Freedom Tax Relief Act of 2007
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S 3261) FY09 Transportation Bills - funding related to transit. House (H.R. 6003) and Senate (S 294) Passenger Rail Investment and Improvement Act if 2008 - commuter rail funding. House (H.R. 6052) and Senate (S 3380) Saving Energy Through Public Transportation Act of 2008 - Commuter rail funding. H.R. 3997 and H.R. 1424 - Emergency Economic Stabilization Act of 2008 for potential impact to transit agencies and infrastructure investment.
Defenders of Freedom Tax Relief Act of 2007
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S 3261) FY09 Transportation Bills - funding related to transit. House (H.R. 6003) and Senate (S 294) Passenger Rail Investment and Improvement Act if 2008 - commuter rail funding. House (H.R. 6052) and Senate (S 3380) Saving Energy Through Public Transportation Act of 2008 - Commuter rail funding. H.R. 3997 and H.R. 1424 - Emergency Economic Stabilization Act of 2008 for potential impact to transit agencies and infrastructure investment. Paul Wellstone Mental Health & Addiction Equity Act of 2007. Public Law 110-374
Renewable Energy and Energy Conservation Tax Act of 2008
Client: STARK & ROTH INC · Firm: SIGNAL GROUP CONSULTING, LLC
HR. 5351- Renewable Energy & Energy Conservation Tax Act of 2008 HR. 2419- Farm, Nutrition & Bioenergy Act of 2007
Renewable Energy and Energy Conservation Tax Act of 2008
Client: STARK & ROTH INC · Firm: SIGNAL GROUP CONSULTING, LLC
S. 1766- Low Carbon Economy Act S. 280- Climate Stewardship & innovation Act of 2007 HR. 5351- Renewable Energy & Energy Conservation Tax Act of 2008 HR. 2419- Farm, Nutrition & Bioenergy Act of 2007
Passenger Rail Investment and Improvement Act of 2008
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
FY 09 Budget resolution, FY 09 Budget submission related to transit, FY 09 Transportation Appropriations Bills; funding related to transit. Amtrak Reauthorization H.R. 6003, S. 294, H.R. 6052 The Saving Energy Through Public Transportation Act of 2008.
Passenger Rail Investment and Improvement Act of 2008
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S 3261) FY09 Transportation Bills - funding related to transit. House (H.R. 6003) and Senate (S 294) Passenger Rail Investment and Improvement Act if 2008 - commuter rail funding. House (H.R. 6052) and Senate (S 3380) Saving Energy Through Public Transportation Act of 2008 - Commuter rail funding. H.R. 3997 and H.R. 1424 - Emergency Economic Stabilization Act of 2008 for potential impact to transit agencies and infrastructure investment.
Passenger Rail Investment and Improvement Act of 2008
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S 3261) FY09 Transportation Bills - funding related to transit. House (H.R. 6003) and Senate (S 294) Passenger Rail Investment and Improvement Act if 2008 - commuter rail funding. House (H.R. 6052) and Senate (S 3380) Saving Energy Through Public Transportation Act of 2008 - Commuter rail funding. H.R. 3997 and H.R. 1424 - Emergency Economic Stabilization Act of 2008 for potential impact to transit agencies and infrastructure investment. Paul Wellstone Mental Health & Addiction Equity Act of 2007. Public Law 110-374
Saving Energy Through Public Transportation Act of 2008
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
FY 09 Budget resolution, FY 09 Budget submission related to transit, FY 09 Transportation Appropriations Bills; funding related to transit. Amtrak Reauthorization H.R. 6003, S. 294, H.R. 6052 The Saving Energy Through Public Transportation Act of 2008.
Saving Energy Through Public Transportation Act of 2008
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S 3261) FY09 Transportation Bills - funding related to transit. House (H.R. 6003) and Senate (S 294) Passenger Rail Investment and Improvement Act if 2008 - commuter rail funding. House (H.R. 6052) and Senate (S 3380) Saving Energy Through Public Transportation Act of 2008 - Commuter rail funding. H.R. 3997 and H.R. 1424 - Emergency Economic Stabilization Act of 2008 for potential impact to transit agencies and infrastructure investment.
Saving Energy Through Public Transportation Act of 2008
Client: CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S 3261) FY09 Transportation Bills - funding related to transit. House (H.R. 6003) and Senate (S 294) Passenger Rail Investment and Improvement Act if 2008 - commuter rail funding. House (H.R. 6052) and Senate (S 3380) Saving Energy Through Public Transportation Act of 2008 - Commuter rail funding. H.R. 3997 and H.R. 1424 - Emergency Economic Stabilization Act of 2008 for potential impact to transit agencies and infrastructure investment. Paul Wellstone Mental Health & Addiction Equity Act of 2007. Public Law 110-374
Maritime Pollution Prevention Act of 2008
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Corp of Engineers, Port Security modification, Passenger Vessel Service Act of 1993. HR 802 Maritime Pollution Prevention Act of 2008- issues related to seaport regulation.
Maritime Pollution Prevention Act of 2008
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Corp of Engineers, Port Security modification, Passenger Vessel Service Act of 1993. HR 802 Maritime Pollution Prevention Act of 2008- issues related to seaport regulation.
Maritime Pollution Prevention Act of 2008
Client: PORT OF SEATTLE · Firm: SIGNAL GROUP CONSULTING, LLC
Corp of Engineers, Port Security, Passenger Vessel Service Act HR 802 Maritime Pollution Prevention Act of 2008
S. 1766- Low Carbon Economy Act S. 280- Climate Stewardship & innovation Act of 2007 HR. 5351- Renewable Energy & Energy Conservation Tax Act of 2008 HR. 2419- Farm, Nutrition & Bioenergy Act of 2007
Climate change S. 1766- Low Carbon Economy Act S. 280- Climate Stewardship & innovation Act of 2007
Climate Stewardship and Innovation Act of 2007
Client: STARK & ROTH INC · Firm: SIGNAL GROUP CONSULTING, LLC
S. 1766- Low Carbon Economy Act S. 280- Climate Stewardship & innovation Act of 2007 HR. 5351- Renewable Energy & Energy Conservation Tax Act of 2008 HR. 2419- Farm, Nutrition & Bioenergy Act of 2007
Climate Stewardship and Innovation Act of 2007
Client: STARK & ROTH INC · Firm: SIGNAL GROUP CONSULTING, LLC
Climate change S. 1766- Low Carbon Economy Act S. 280- Climate Stewardship & innovation Act of 2007
Department of Homeland Security Appropriations Act, 2009
Client: CORRECTIONS CORPORATION OF AMERICA · Firm: SIGNAL GROUP CONSULTING, LLC
HR 2642 (PL 110- 252) the FY 2008 Emergency Supplemental Appropriations Bill provisions and funding related to Bureau of Prisons (BOP); The Office of Federal Detention Trustee (OFDT) S. 3181 FY 09 Senate Homeland Security Approps bill provisions and funding related to Immigration and Customs Enforcement (ICE). S. 3182 FY09, Senate CJS Approps bill provisions and funding related to Bureau of Prisons (BOP) and The Office of Federal Detention Trustee (OFDT).
Department of Homeland Security Appropriations Act, 2009
Client: CORRECTIONS CORPORATION OF AMERICA · Firm: SIGNAL GROUP CONSULTING, LLC
House FY 2009 Homeland Security Appropriations Bill-Issues related to Immigration and Customs Enforcement. S. 3181, Senate FY 2009 HS Approps Bill Issues related to Immigration and Customs Enforcement (ICE).
Department of Homeland Security Appropriations Act, 2009
Client: CORRECTIONS CORPORATION OF AMERICA · Firm: SIGNAL GROUP CONSULTING, LLC
House FY 2009 Homeland Security Appropriations Bill-Issues related to Immigration and Customs Enforcement. S. 3181, Senate FY 2009 Homeland Security Approps Bill Issues related to Immigration and Customs Enforcement (ICE).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2009
Client: PARTNERSHIP FOR A DRUG FREE AMERICA · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S. 3182) FY 2009 Commerce, Justice, and Science Appropriations Bill - Additional funding for drug abuse prevention program House and Senate (S. 3230) FY 2009 Labor, Health and Human Services Appropriations Bill - Additional funding for drug abuse prevention program
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2009
Client: CORRECTIONS CORPORATION OF AMERICA · Firm: SIGNAL GROUP CONSULTING, LLC
HR 2642 (PL 110- 252) the FY 2008 Emergency Supplemental Appropriations Bill provisions and funding related to Bureau of Prisons (BOP); The Office of Federal Detention Trustee (OFDT) S. 3181 FY 09 Senate Homeland Security Approps bill provisions and funding related to Immigration and Customs Enforcement (ICE). S. 3182 FY09, Senate CJS Approps bill provisions and funding related to Bureau of Prisons (BOP) and The Office of Federal Detention Trustee (OFDT).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2009
Client: PARTNERSHIP FOR A DRUG FREE AMERICA · Firm: SIGNAL GROUP CONSULTING, LLC
House and Senate (S. 3182) - FY 2009 Commerce, Justice, and Science Appropriations Bill - Additional funding for drug abuse prevention program House and Senate - FY 2009 (S. 3230) Labor, Health, and Human Services Appropriations Bills - Additonal funding for drug abuse prevention program
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: COMMUNITY MEDICAL CENTER · Firm: SIGNAL GROUP CONSULTING, LLC
FY 2009 House and Senate (S. 3230) Labor HHS Education Appropriations Bills-funding related to Community Medical Center projects and programs.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: COMMUNITY MEDICAL CENTER · Firm: SIGNAL GROUP CONSULTING, LLC
FY 2009 House and Senate (S. 3230) Labor HHS Education Appropriations Bills-funding related to Community Medical Center projects and programs.
Issues related to DOD biofuels policy and procurement.
Issues related to federal biofuels policy.
Agriculture funding.
Issues related to federal alternative fuels policy.
Monitored education priorities and possible funding mechanisms; FY2012 Appropriations; and issues related to higher education. Issues related to graduate medical education.
Issues related to aviation biofuels - advocated on behalf of the creation of a Center of Excellence for aviation biofuels.
Graduate Medical education; monitored health care reform; Health care Repeal bills; and issues related to health care and Medicare policy.
Issues related to Brownfields and soil remediation.
Monitored FAA Reauthorization bill - advocated on behalf of the creation of a Center of Excellence for aviation biofuels.
Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2012 · first_quarter · 1T
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2012 · first_quarter · 1T
Issues related to intellectual property protections in foreign trade agreements.
Issues related to the development of new medical therapies.
Issues related to policy changes to Medicare Part B & D.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Issues related to the impact of the bio-pharmaceutical industry on the economy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2012 · first_quarter · 1T
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2012 · first_quarter · Q1
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding. Advocated for funding in FY2013 DOD Budget. Monitored House and Senate hearing process. US Navy shipbuilding programs.
Navy shipbuilding as part of FY2013 PB for DOD. Monitored issues related to funding of "Green Fleet" initiatives in Navy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · 2T
Research and development for medical device technology. Monitored issues surrounding medical technology. Worked for inclusion of patient status monitor funds in the FY2012 Defense Authorization and Appropriations bills.
Research and development for medical device technology.
Appropriations request for FY2012 DoD Research and Development project. Advocated for funding in the FY2012 DoD Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · Q4
Issues related to Brownfields and soil remediation.
Issues related to federal alternative fuels policy.
Monitored FAA Reauthorization bill.
CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · Q4
Monitored implementation of the American Recovery and Reinvestment Act of 2009 (PL 111-5) for transit and rail funding, the FY2012 Transportation, Housing and Urban Development (PL 112-55). Monitored the FY2012 Budget request for funding for transit programs. FY2012 Continuing Resolutions. Competitive grant opportunities for transit organizations. TIGER. The American Jobs Act.
Filing targets: Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · Q4
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · Q4
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Issues related to the development of new medical therapies.
Issues related to intellectual property protections in foreign trade agreements.
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · Q4
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · Q4
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding. Advocated for funding in FY2012 DOD Appropriations bill. Monitored House and Senate DOD Authorization and Appropriations bills (FY2012). US Navy shipbuilding programs.
Navy shipbuilding as part of FY2012 PB for DOD. Monitored issues related to funding of "Green Fleet" initiatives in Navy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
DAVIS WRIGHT TREMAINE LLP (ON BEHALF OF SWEDISH MEDICAL CTR & PROVIDENCE HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · fourth_quarter · 4T
Issues related to the affiliation between Providence and Swedish medical provider systems in Washington State.
Issues related to the affiliation between Providence and Swedish medical provider systems in Washington State.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · 3A
FY2012 Continuing Resolution. Agriculture funding.
Issues related to biofuels policy and procurement.
Issues related to federal stormwater policy and issues related to biomass and forestry.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · 2A
Issues related to federal stormwater policy and issues related to biomass and forestry.
Issues related to federal biofuels policy.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · 1A
Issues related to federal biofuels policy.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research.
Issues related to federal stormwater policy and issues related to biomass and forestry.
DAVIS WRIGHT TREMAINE LLP (ON BEHALF OF SWEDISH MEDICAL CTR & PROVIDENCE HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Issues related to the affiliation between Providence and Swedish medical provider systems in Washington State.
Issues related to the affiliation between Providence and Swedish medical provider systems in Washington State.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVIS WRIGHT TREMAINE LLP (ON BEHALF OF SWEDISH MEDICAL CTR & PROVIDENCE HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · RR
Issues related to Swedish Medical Center and Providence Health affiliation.
Issues related to Swedish Medical Center and Providence Health affiliation.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Monitored education priorities and possible funding mechanisms; FY2012 Appropriations; and issues related to higher education.
Issues related to biofuels policy and procurement.
Issues related to federal stormwater policy and issues related to biomass and forestry.
CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Monitored implementation of the American Recovery and Reinvestment Act of 2009 (PL 111-5) for transit funding, the FY2011 Transportation, Housing and Urban Development, and Related Agencies. Monitored the FY2012 Budget request for funding for transit programs. FY2011 Continuing Resolutions. Competitive grant opportunities for transit organizations. TIGER. The American Jobs Act.
Filing targets: Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Issues related to the development of new medical therapies.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Issues related to the impact of the bio-pharmaceutical industry on the economy.
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding. Advocated for funding in FY2012 DOD Appropriations bill. Monitored House and Senate DOD Authorization and Appropriations bills (FY2012). US Navy shipbuilding programs.
Navy shipbuilding as part of FY2012 PB for DOD. Monitored issues related to funding of "Green Fleet" initiatives in Navy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
JPMORGAN CHASE & CO. via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Monitored foreclosure prevention proposals, loan limits and activity on housing issues. Monitored and advocated on reform of GSE/housing finance system. Monitored and advocated on issues impacting mortgage servicing. Monitored activity on mortgages and lending including housing finance reform.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
DOWNLOAD FAIRNESS COALITION via SIGNAL GROUP CONSULTING, LLC
2011 · third_quarter · Q3
Issues related to taxation of digital goods.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · 1A
Research and development for medical device technology.
Appropriations request for FY2011 DOD Research and Development project. Advocated for funding in the FY2011 DOD Appropriations bill.
Research and development for medical device technology. Monitored issues surrounding medical technology. Worked for inclusion of patient status monitor funds in the FY2012 Defense Authorization bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · 2@
Appropriations request for FY2012 DOD Research and Development project. Advocated for funding in the FY2012 DOD Appropriations bill.
Research and development for medical device technology.
Research and development for medical device technology. Monitored issues surrounding medical technology. Worked for inclusion of patient status monitor funds in the FY2012 Defense Authorization and Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · Q2
Monitored FAA Reauthorization bill.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research.
Issues related to biofuels policy and procurement.
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · Q2
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · Q2
Appropriations request for FY2012 DOD Research and Development project. Advocated for funding in the FY2012 DOD Appropriations bill.
Research and development for medical device technology.
Research and development for medical device technology. Monitored issues surrounding medical technology. Worked for inclusion of patient status monitor funds in the FY2012 Defense Authorization and Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · Q2
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · Q2
DOD procurement related to Navy shipbuilding.
Navy shipbuilding as part of FY2012 PB for DOD. Monitored issues related to funding of "Green Fleet" initiatives in Navy.
DOD procurement related to Navy shipbuilding. Advocated for funding in FY2012 DOD Appropriations bill. Conferred with officials regarding overseas military sales program. Monitored House and Senate DOD Authorization and Appropriations bills (FY2012).
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · second_quarter · Q2
Issues related to the development of new medical therapies.
Issues related to patent reform legislation (H.R.1249 & S.23).
Issues related to the impact of the bio-pharmaceutical industry on the economy.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
Monitored FAA Reauthorization bill.
Issues related to federal stormwater policy and issues related to biomass and forestry.
Issues related to federal biofuels policy.
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
Research and development for medical device technology. Monitored issues surrounding medical technology. Worked for inclusion of patient status monitor funds in the FY2012 Defense Authorization bill.
Research and development for medical device technology.
Appropriations request for FY2011 DOD Research and Development project. Advocated for funding in the FY2011 DOD Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
Issues related to patent reform legislation (S.23, America Invents Act).
Issues related to the impact of the bio-pharmaceutical industry on the economy.
Issues related to the development of new medical therapies.
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117). Issues related to the development of Building Star and the CEDA or "green bank" program under development.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DOWNLOAD FAIRNESS COALITION via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · Q1
Issues related to taxation of digital goods.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DOWNLOAD FAIRNESS COALITION via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · RA
Digital Tax Fairness.
DOWNLOAD FAIRNESS COALITION via SIGNAL GROUP CONSULTING, LLC
2011 · first_quarter · RR
Digital Tax Fairness.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · 4A
FY2011 Omnibus and Continuing Resolution.
Monitored education priorities and possible funding mechanisms; FY2011 Appropriations; and issues related to higher education.
Issues related to federal alternative fuels policy.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · Q4
Issues related to federal stormwater policy and issues related to biomass and forestry.
Monitored education priorities and possible funding mechanisms; FY2011 Appropriations; and issues related to higher education.
Issues related to federal alternative fuels policy.
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · Q4
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · 4T
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to land development.
Filing targets: Army, Dept of (Corps of Engineers), SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · Q4
Research and development for medical device technology.
Appropriations request for FY2011 DOD Research and Development project. Advocated for funding in the FY2011 DOD Appropriations bill.
Research and development for medical device technology. Monitored issues surrounding medical technology.
Filing targets: SENATE
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · Q4
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117). Issues related to the development of Building Star and the CEDA or "green bank" program under development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · Q4
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · Q4
Issues related to the impact of the bio-pharmaceutical industry on the economy.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Issues related to the development of new medical therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · RA
Issues related to Fraternal's 501(c)(8) tax exempt status.
Issues related to Fraternal's 501(c)(8) tax exempt status.
Issues related to Fraternal's 501(c)(8) tax exempt status.
WASHINGTON STATE UNIVERSITY via SIGNAL GROUP CONSULTING, LLC
2010 · fourth_quarter · RR
Land Grant Universities in 2012; biofuels; low impact development; energy grid; human health education; agricultural research; support for higher education and higher education policy; stormwater.
Land Grant Universities in 2012; biofuels; low impact development; energy grid; human health education; agricultural research; support for higher education and higher education policy; stormwater.
Land Grant Universities in 2012; biofuels; low impact development; energy grid; human health education; agricultural research; support for higher education and higher education policy; stormwater.
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to land development.
Filing targets: Army, Dept of (Corps of Engineers), SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
Appropriations request for FY2011 DOD Research and Development project. Advocated for funding in the FY2011 DOD Appropriations bill.
Research and development for medical device technology. Monitored issues surrounding medical technology.
Research and development for medical device technology.
Filing targets: SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
Issues related to the impact of the bio-pharmaceutical industry on the economy.
Issues related to the development of new medical therapies.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117). Issues related to the development of Building Star and the CEDA or "green bank" program under development.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALISPEL TRIBE OF INDIANS via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · 3T
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
GIGOPTIX INC via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
H.R.3326, FY2010 DOD Appropriations bill (PL 111-118)- funding for polymer-based optical communications technology. Issues related to congressional consideration of President's defense budget. The FY2011 House and Senate DOD Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY MEDICAL CENTER via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · Q3
FY2011 House and Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bills (S.3686)- advocated for funding related to Community Medical Center projects and programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIXKILLER CONSULTING, LLC via SIGNAL GROUP CONSULTING, LLC
2010 · third_quarter · RR
Monitor Congressional activity related to the Indian Gaming Regulatory Act.
Monitor Congressional activity related to the Indian Gaming Regulatory Act.
Monitor Congressional activity related to the Indian Gaming Regulatory Act.
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to land development.
Issues related to salmon habitat.
Filing targets: Army, Dept of (Corps of Engineers), SENATE
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
Appropriations request for FY2011 Research and Development project. Advocated for funding in the FY2011 House and Senate DOD Appropriations bills.
Research and development for medical device technology.
Research and development for medical device technology. Monitored issues surrounding medical technology.
Filing targets: SENATE
PORT OF SEATTLE via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
FY2011 Transportation, Housing and Urban Development and Related Agencies Appropriations bill- funding for local governments. Potential legislation related to economic stimulus and jobs. Monitored the FY2011 budget request.
Filing targets: Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Maritime Commission, HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
Issues related to the impact of the bio-pharmaceutical industry on the economy.
Issues related to the development of new medical therapies.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
Monitored tax reform issues.
Monitored and advocated on financial regulatory reform efforts including treatment of insurance business and assessments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117). Issues related to the development of Building Star and the CEDA or "green bank" program under development.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
DOD procurement related to Navy shipbuilding.
DOD procurement related to Navy shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALISPEL TRIBE OF INDIANS via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · Q2
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, SENATE
GREATPOINT ENERGY via SIGNAL GROUP CONSULTING, LLC
2010 · second_quarter · 2T
Issues related to trade, commerce,and international project development.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, SENATE
KALISPEL TRIBE OF INDIANS via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · Q1
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Legislation to modify leasing provisions for lands held by certain Indian Tribes (H.R.4401, S.2906). Prevent all Cigarette Trafficking Act (PL 111-117).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · Q1
DOD procurement.
DOD procurement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · Q1
Issues related to land development near existing wetlands.
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to salmon habitat.
Filing targets: Natl Oceanic & Atmospheric Administration (NOAA), U.S. Fish & Wildlife Service (USFWS)
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · Q1
Research and development for medical device technology. Monitored issues surrounding medical technology.
Research and development for medical device technology.
Appropriations request for FY2011 Research and Development project. Advocated for funding in the FY2011 House and Senate DOD Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · Q1
America's Healthy Future Act of 2009- issues related to Medicare Part D.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · Q1
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117). Issues related to the development of Building Star and the CEDA or "green bank" program under development.
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
J.M. MARTINAC SHIPBUILDING CORPORATION via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · RA
DOD procurement.
DOD procurement.
PYNG MEDICAL USA via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · RR
Development of advanced medical technologies.
Development of advanced medical technologies.
Development of advanced medical technologies.
AMERICAN FRATERNAL ALLIANCE (FKA NATIONAL FRATERNAL CONGRESS OF AMERICA) via SIGNAL GROUP CONSULTING, LLC
2010 · first_quarter · RR
Issues related to Fraternal's 501(c)(8) tax exempt status.
Issues related to Fraternal's 501(c)(8) tax exempt status.
Issues related to Fraternal's 501(c)(8) tax exempt status.
BOEING COMPANY via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Outreach regarding the World Trade Organization's action on Large Civil Aircraft.
Issues related to Navy tactical aircraft; Air Force cargo and aerial refueling aircraft; ground combat modernization systems; Navy maritime aviation programs; Marine Corps aviation programs; and missile defense programs.
Issues related to Navy tactical aircraft; Air Force aerial refueling and cargo aircraft; ground combat modernization systems; Navy maritime aviation programs; Marine Corps aviation programs; missile defense programs; H.R.3326, FY2010 DOD Appropriations bill (PL 111-118); H.R.2647, National Defense Authorization Act for FY2010; S.1390, FY2010 National Defense Authorization Act; and H.R.3288, FY2010 Transportation-HUD Appropriations Act (PL 111-117).
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Issues related to land development near existing wetlands.
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to salmon habitat.
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; America's Healthy Future Act of 2009- issues related to importation of pharmaceutical products from foreign countries.
America's Healthy Future Act of 2009- issues related to Medicare Part D.
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Issues related to energy efficiency in the Federal built-environment & ESPC contracting. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Issues related to Federal land use policy, forest fire protection, and biomass.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
KALISPEL TRIBE OF INDIANS via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Legislation to modify leasing provisions for lands held by certain Indian Tribes (H.R.4401, S.2906).
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JPMORGAN CHASE & CO. via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117). H.R.3288, FY2010 Transportation-HUD Appropriations Act (PL 111-117) and Surface Transportation Authorization Act of 2009.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of
GOOGLE, INC. via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Monitored energy issues and climate change.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENTERPRISE COMMUNITY PARTNERS, INC. via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · Q4
Monitored and advocated on energy efficiency including Green Act and H.R.2454, the American Clean Energy and Security Act and Senate energy bill, S.1462, the American Clean Energy Leadership Act of 2009. Analyzed opportunities in Department of Energy programs, including weatherization. Advocated for energy efficiency multifamily housing funding. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Housing and community development funding. Monitored budget and appropriations process for housing and community development programs, including section 4 (HUD) funding in H.R.3288, the FY2010 Transportation-HUD Appropriations bill (PL 111-117).
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · RA
Levee construction, real estate development and environmental mitigation.
Levee construction, real estate development and environmental mitigation.
Levee construction, real estate development and environmental mitigation.
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2009 · fourth_quarter · RR
Levee construction, real estate development and environmental mitigation.
Levee construction, real estate development and environmental mitigation.
Levee construction, real estate development and environmental mitigation.
RENAISSANCERE HOLDINGS LTD. via SIGNAL GROUP CONSULTING, LLC
2009 · second_quarter · RA
Track, monitor and advocate on natural disaster insurance issues, as well as mitigation efforts. Monitor flood and wind insurance issues.
Track, monitor and advocate on natural disaster insurance issues, as well as mitigation efforts. Monitor flood and wind insurance issues.
Track, monitor and advocate on natural disaster insurance issues, as well as mitigation efforts. Monitor flood and wind insurance issues.
CENTRAL PUGET SOUND REGIONAL TRANSIT AUTHORITY via SIGNAL GROUP CONSULTING, LLC
2009 · third_quarter · Q3
Monitored legislative activity related to the Surface Transportation Authorization Act of 2009, including high priority projects. Monitored legislative activity around the SILO/LILO Loophole Act (H.R. 3439/S. 1341, Close the SILO/LILO Loophole Act of 2009). Issues related to local project planning and finance.
Monitored implementation of H.R. 1, the American Recovery and Reinvestment Act of 2009 (PL: 111-5) for transit funding. H.R. 3288, Transporation, Housing and Urban Development, and Related Agencies Approprations Act FY2010- funding to support local initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2009 · third_quarter · 3T
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to salmon habitat.
Filing targets: Federal Emergency Management Agency (FEMA), Natl Oceanic & Atmospheric Administration (NOAA), SENATE
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2009 · third_quarter · Q3
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
America's Healthy Future Act of 2009 -issues related to Medicare Part D.
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2009 · third_quarter · Q3
Issues related to Federal land use policy and forest fire protection.
Issues related to Federal land use policy and forest fire protection.
Issues related to the Clean Energy and Security Act and the American Clean Energy Leadership Act. Issues related to energy efficiency in the Federal built-environment & ESPC contracting.
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
KALISPEL TRIBE OF INDIANS via SIGNAL GROUP CONSULTING, LLC
2009 · third_quarter · Q3
Monitored legislation affecting Federally recognized Indian Tribes.
Monitored legislative and regulatory activity related to the Indian Gaming Regulatory Act.
Filing targets: HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
MCKINSTRY CO. via SIGNAL GROUP CONSULTING, LLC
2009 · third_quarter · RR
Carbon policy/climate change, tax policy related to energy, energy and transmission policy.
Carbon policy/climate change, tax policy related to energy, energy and transmission policy.
Carbon policy/climate change, tax policy related to energy, energy and transmission policy.
PHRMA (ON BEHALF OF WE WORK FOR HEALTH) via SIGNAL GROUP CONSULTING, LLC
2009 · second_quarter · Q2
Issues related to the impact of the bio-pharmaceutical industry on the economy of Washington State. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
SEGALE PROPERTIES via SIGNAL GROUP CONSULTING, LLC
2009 · second_quarter · Q2
Issues related to levy upgrades and environmental mitigation efforts.
Issues related to salmon habitat.
Filing targets: Commerce, Dept of (DOC), SENATE
Issues related to DOD biofuels policy and procurement.
Graduate Medical education; monitored health care reform; Health care Repeal bills; and issues related to health care and Medicare policy.
FY2012 Continuing Resolution. Agriculture funding.
Issues related to federal biofuels policy.
Monitored education priorities and possible funding mechanisms; FY2012 Appropriations; and issues related to higher education. Issues related to graduate medical education.
Issues related to federal stormwater policy and issues related to biomass and forestry.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research. Issues related to agriculture research; issues related to veterinary medicine.
Issues related to aviation biofuels.
Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
Issues related to the impact of the bio-pharmaceutical industry on the economy.
Issues related to policy changes to Medicare Part B & D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to federal alternative fuels policy.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research. Issues related to agriculture research; issues related to veterinary medicine.
Graduate Medical education; monitored health care reform; Health care Repeal bills; and issues related to health care and Medicare policy.
Issues related to federal biofuels policy.
Issues related to Brownfields and soil remediation.
Monitored education priorities and possible funding mechanisms; FY2012 Appropriations; and issues related to higher education.
Monitored FAA Reauthorization bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitored FAA Reauthorization bill.
Issues related to biofuels policy and procurement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitored FAA Reauthorization bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research. Issues related to agriculture research; issues related to veterinary medicine.
Monitored FAA Reauthorization bill.
FY2012 Continuing Resolution. Agriculture funding.
Issues related to Brownfields and soil remediation.
Issues related to federal biofuels policy.
Issues related to federal alternative fuels policy.
Graduate Medical education; monitored health care reform; Health care Repeal bills; and issues related to health care and Medicare policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to patent reform legislation (H.R.1249 & S.23).
Issues related to intellectual property protections in foreign trade agreements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to federal biofuels policy.
Issues related to federal stormwater policy and issues related to biomass and forestry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Issues related to intellectual property protections in foreign trade agreements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Graduate Medical education; monitored health care reform; Health care Repeal bills; and issues related to health care and Medicare policy.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research.
Issues related to federal stormwater policy and issues related to biomass and forestry.
Issues related to federal biofuels policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Graduate Medical education; monitored health care reform; Health care Repeal bills; and issues related to health care and Medicare policy.
Issues related to Farm Bill reauthorization and Title IX of Farm Bill; Securing resources for agricultural and food research.
Issues related to federal biofuels policy.
FY2011 Omnibus and Continuing Resolution.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Fraternal's 501(c)(8) tax exempt status.
Land Grant Universities in 2012; biofuels; low impact development; energy grid; human health education; agricultural research; support for higher education and higher education policy; stormwater.
Land Grant Universities in 2012; biofuels; low impact development; energy grid; human health education; agricultural research; support for higher education and higher education policy; stormwater.
Land Grant Universities in 2012; biofuels; low impact development; energy grid; human health education; agricultural research; support for higher education and higher education policy; stormwater.
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Filing targets: SENATE
Issues related to Fraternal's 501(c)(8) tax exempt status.
Filing targets: Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Issues related to the development of new medical therapies. H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R.1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S.726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Provided support and advocated on energy related issues, including energy efficiency and housing. Monitored and advocated on energy efficiency including Green Act and H.R.2454, the American Clean Energy and Security Act and Senate energy bill, S.1462, the American Clean Energy Leadership Act of 2009. Analyzed opportunities in Department of Energy programs, including weatherization. Advocated for energy efficiency multifamily housing funding. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Provided support on energy efficient housing opportunities in H.R.1, the American Recovery and Reinvestment Act of 2009 (PL 111-5). Monitored and advocated for energy efficient housing provisions in American Clean Energy and Security Act and Senate energy bill, S.1462, the American Clean Energy Leadership Act of 2009. Monitored housing proposals, including Choice Neighborhoods and public housing proposals. Monitored legislative and regulatory action on energy efficient housing. Potential legislation related to economic stimulus and jobs including H.R.2847 as amended, the Commerce, Justice, Science, and Related Agencies Appropriations Act of FY2010 (PL 111-117).
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
Track, monitor and advocate on natural disaster insurance issues, as well as mitigation efforts. Monitor flood and wind insurance issues.
Issues related to the impact of the bio-pharmaceutical industry on the economy. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Carbon policy/climate change, tax policy related to energy, energy and transmission policy.
Issues related to the development of new medical therapies. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; H.R. 1548, Pathway for Biosimilars Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE